← brief for 2026-10-06 · Slowing decline
Comparative Cardiovascular Outcomes of Lanthanum Carbonate and Sevelamer in Dialysis.
Key takeaways
This study compared two common drugs used to control phosphate in people on dialysis. It used a large database to see which drug was linked to better heart health. This is an observational study, so it shows a link between the drugs and heart outcomes, but it does not prove one is better than the other.
Who did this work
Liu J · Jin L · Luo F · Zhou S · She C · Fang R · Zhang Y · Xu X · Nie S
Source
Article · PubMed, CKD progression and prevention · 2026 Oct 6
https://pubmed.ncbi.nlm.nih.gov/42837171/